CEACAM1+ myeloid cells control angiogenesis in inflammation

Blood

Volumn 113, Issue 26, 2009, Pages 6726-6736

  Horst, Andrea K ^a   Bickert, Thomas ^a,b   Brewig, Nancy ^b   Ludewig, Peter ^a   Van Rooijen, Nico ^c   Schumacher, Udo ^a   Beauchemin, Nicole ^d   Ito, Wulf D ^e   Fleischer, Bernhard ^b   Wagener, Christoph ^a   Ritter, Uwe ^b,f  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY OF ULM   (Germany)

^f UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CD11B ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CEACAM1 PROTEIN, MOUSE; COLLAGEN; GAMMA INTERFERON; GLYCOPROTEIN; LAMININ; MATRIGEL; PROTEOGLYCAN; PROTOZOON ANTIBODY; XLKD1 PROTEIN, MOUSE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CONTROLLED STUDY; INFLAMMATION; LYMPHANGIOGENESIS; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN LEISHMANIASIS; WILD TYPE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELLULAR IMMUNITY; CHEMISTRY; CLASSIFICATION; DRUG COMBINATION; EDEMA; GENETICS; IMMUNOLOGY; IMPLANT; LEISHMANIA MAJOR; LYMPH VESSEL; METABOLISM; MOUSE MUTANT; NEOVASCULARIZATION (PATHOLOGY); PARASITOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIATION CHIMERA; TH1 CELL;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, CD11B; BONE MARROW TRANSPLANTATION; CARCINOEMBRYONIC ANTIGEN; COLLAGEN; DRUG COMBINATIONS; EDEMA; GLYCOPROTEINS; IMMUNITY, CELLULAR; IMPLANTS, EXPERIMENTAL; INFLAMMATION; INTERFERON-GAMMA; LAMININ; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPHATIC VESSELS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; NEOVASCULARIZATION, PATHOLOGIC; PROTEOGLYCANS; RADIATION CHIMERA; TH1 CELLS;

EID: 69249229647     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-10-184556     Document Type: Article

References (50)

1. Religa P, Cao R, Bjorndahl M, Zhou Z, Zhu Z, Cao Y. Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels. Blood. 2005;106:4184-4190. (Pubitemid 41775925)
2. Khmelewski E, Becker A, Meinertz T, Ito WD. Tissue resident cells play a dominant role in arteriogenesis and concomitant macrophage accumulation. Circ Res. 2004;95:E56-E64.
3. Ozerdem U, Alitalo K, Salven P, Li A. Contribution of bone marrow-derived pericyte precursor cells to corneal vasculogenesis. Invest Ophthalmol Vis Sci. 2005;46:3502-3506. (Pubitemid 44264649)
4. Zengin E, Chalajour F, Gehling UM, et al. Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development. 2006; 133:1543-1551. (Pubitemid 43732967)
5. Maruyama K, Ii M, Cursiefen C, et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest. 2005;115:2363-2372. (Pubitemid 41266198)
6. Kerjaschki D. The crucial role of macrophages in lymphangiogenesis. J Clin Invest. 2005;115: 2316-2319.
7. Seandel M, Butler J, Lyden D, Rafii S. A catalytic role for proangiogenic marrow-derived cells in tumor neovascularization. Cancer Cell. 2008;13: 181-183. (Pubitemid 351318378)
8. De Palma M, Murdoch C, Venneri MA, Naldini L, Lewis CE. Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. Trends Immunol. 2007;28:519-524. (Pubitemid 350101421)
9. Schoppmann SF, Birner P, Stockl J, et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol. 2002; 161:947-956. (Pubitemid 34988382)
10. Ocklind C, Obrink B. Intercellular adhesion of rat hepatocytes. Identification of a cell surface glycoprotein involved in the initial adhesion process. J Biol Chem. 1982;257:6788-6795.
11. Gray-Owen SD, Blumberg RS. CEACAM1: contact-dependent control of immunity. Nat Rev Immunol. 2006;6:433-446.
12. Kuespert K, Pils S, Hauck CR. CEACAMs: their role in physiology and pathophysiology. Curr Opin Cell Biol. 2006;18:565-571. (Pubitemid 44332912)
13. Horst AK, Ito WD, Dabelstein J, et al. Carcinoembryonic antigen-related cell adhesion molecule 1 modulates vascular remodeling in vitro and in vivo. J Clin Invest. 2006;116:1596-1605. (Pubitemid 43911013)
14. Ritter U, Moll H. Monocyte chemotactic protein-1 stimulates the killing of leishmania major by human monocytes, acts synergistically with IFN-gamma and is antagonized by IL-4. Eur J Immunol. 2000;30:3111-3120. (Pubitemid 30846026)
15. Ritter U, Moll H, Laskay T, et al. Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J Infect Dis. 1996;173:699-709. (Pubitemid 26069667)
16. Ritter U, Korner H. Divergent expression of inflammatory dermal chemokines in cutaneous leishmaniasis. Parasite Immunol. 2002;24:295-301. (Pubitemid 34779848)
17. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature. 2002;420:502-507.
18. Bogdan C, Gessner A, Solbach W, Rollinghoff M. Invasion, control and persistence of Leishmania parasites. Curr Opin Immunol. 1996;8:517-525. (Pubitemid 26280781)
19. Alexander J, Satoskar AR, Russell DG. Leishmania species: models of intracellular parasitism. J Cell Sci. 1999;112(Pt 18):2993-3002. (Pubitemid 29465717)
20. Hemmila E, Turbide C, Olson M, Jothy S, Holmes KV, Beauchemin N. Ceacam1a-/- mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59. J Virol. 2004; 78:10156-10165. (Pubitemid 39187133)
21. Leung N, Turbide C, Olson M, Marcus V, Jothy S, Beauchemin N. Deletion of the carcinoembryonic antigen-related cell adhesion molecule 1 (Ceacam1) gene contributes to colon tumor progression in a murine model of carcinogenesis. Oncogene. 2006;25:5527-5536. (Pubitemid 44344103)
22. Ritter U, Mattner J, Rocha JS, Bogdan C, Korner H. The control of Leishmania (Leishmania) major by TNF in vivo is dependent on the parasite strain. Microbes Infect. 2004;6:559-565. (Pubitemid 38680597)
23. Zelus BD, Wessner DR, Williams RK, et al. Purified, soluble recombinant mouse hepatitis virus receptor, Bgp1 (b), and Bgp2 murine coronavirus receptors differ in mouse hepatitis virus binding and neutralizing activities. J Virol. 1998;72:7237-7244.
24. Weiss R, Scheiblhofer S, Thalhamer J, et al. Epidermal inoculation of Leishmania-antigen by gold bombardment results in a chronic form of leishmaniasis. Vaccine. 2007;25:25-33. (Pubitemid 44855255)
25. Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods. 1994;174:83-93. (Pubitemid 24297139)
26. van Rooijen N, van Kesteren-Hendrikx E. "In vivo" depletion of macrophages by liposome-mediated "suicide". Methods Enzymol. 2003;373: 3-16.
27. Sunderkotter C, Nikolic T, Dillon MJ, et al. Sub-populations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol. 2004;172:4410-4417. (Pubitemid 38375256)
28. Jeon BH, Jang C, Han J, et al. Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer. Cancer Res. 2008;68:1100-1109. (Pubitemid 351272228)
29. Elghetany MT. Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells Mol Dis. 2002;28:260-274.
30. Sandilands GP, Ahmed Z, Perry N, Davison M, Lupton A, Young B. Cross-linking of neutrophil CD11b results in rapid cell surface expression of molecules required for antigen presentation and T-cell activation. Immunology. 2005;114:354-368. (Pubitemid 40314808)
31. Yu Q, Chow EM, Wong H, et al. CEACAM1 (CD66a) promotes human monocyte survival via a phosphatidylinositol 3-kinase- and AKT-dependent pathway. J Biol Chem. 2006;281: 39179-39193. (Pubitemid 46041878)
32. Nakajima A, Iijima H, Neurath MF, et al. Activation-induced expression of carcinoembryonic antigen-cell adhesion molecule 1 regulates mouse T lymphocyte function. J Immunol. 2002; 168:1028-1035. (Pubitemid 34094465)
33. Markel G, Lieberman N, Katz G, et al. CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity. J Immunol. 2002;168: 2803-2810. (Pubitemid 34211659)
34. Prall F, Nollau P, Neumaier M, et al. CD66a (BGP), an adhesion molecule of the carcinoembryonic antigen family, is expressed in epithelium, endothelium, and myeloid cells in a wide range of normal human tissues. J Histochem Cytochem. 1996;44:35-41. (Pubitemid 26010670)
35. Schledzewski K, Falkowski M, Moldenhauer G, et al. Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis. J Pathol. 2006;209:67-77.
36. Du R, Lu KV, Petritsch C, et al. HIF1[alpha] induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell. 2008;13: 206-220. (Pubitemid 351318372)
37. Rafii S, Lyden D. Cancer. A few to flip the angiogenic switch. Science. 2008;319:163-164.
38. Cursiefen C, Maruyama K, Jackson DG, Streilein JW, Kruse FE. Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea. 2006;25:443-447. (Pubitemid 44620130)
39. Maruyama K, Asai J, Ii M, Thorne T, Losordo DW, D'Amore PA. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol. 2007;170:1178-1191. (Pubitemid 47339326)
40. Skubitz KM, Campbell KD, Skubitz AP. Synthetic peptides from the N-domains of CEACAMs activate neutrophils. J Pept Res. 2001;58:515-526.
41. Ergun S, Kilic N, Ziegeler G, et al. CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. Mol Cell. 2000;5:311-320. (Pubitemid 30628089)
42. Chen WJ, Chen HW, Yu SL, et al. Gene expression profiles in hypoxic preconditioning using cDNA microarray analysis: altered expression of an angiogenic factor, carcinoembryonic antigen-related cell adhesion molecule 1. Shock. 2005; 24:124-131.
43. Kilic N, Oliveira-Ferrer L, Wurmbach JH, et al. Pro-angiogenic signaling by the endothelial presence of CEACAM1. J Biol Chem. 2005;280:2361-2369.
44. Hong YK, Foreman K, Shin JW, et al. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet. 2004;36:683-685. (Pubitemid 38886627)
45. Kilic N, Oliveira-Ferrer L, Neshat-Vahid S, et al. Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1. Blood. 2007;110:4223-4233.
46. Hirakawa S, Hong YK, Harvey N, et al. Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am J Pathol. 2003; 162:575-586. (Pubitemid 36267864)
47. Hong YK, Harvey N, Noh YH, et al. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn. 2002; 225:351-357. (Pubitemid 35265813)
48. Oliveira-Ferrer L, Tilki D, Ziegeler G, et al. Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer. Cancer Res. 2004;64:8932-8938. (Pubitemid 39665500)
49. Tilki D, Irmak S, Oliveira-Ferrer L, et al. CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer. Oncogene. 2006;25:4965-4974. (Pubitemid 44246355)
50. Obrink B. Is CEACAM1 a lymphangiogenic switch? Blood. 2007;110:4137-4138.